Enwei Pharmaceutical Co., Ltd. (SHE:301331)
19.35
-0.81 (-4.02%)
At close: Jul 30, 2026
-47.45% (1Y)
| Market Cap | 1.97B -47.0% |
| Revenue (ttm) | 879.60M +6.6% |
| Net Income | 48.14M +6.1% |
| EPS | 0.46 +2.7% |
| Shares Out | 101.88M |
| PE Ratio | 41.74 |
| Forward PE | n/a |
| Dividend | 0.66 (3.27%) |
| Ex-Dividend Date | May 28, 2026 |
| Volume | 3,128,417 |
| Open | 19.87 |
| Previous Close | 20.16 |
| Day's Range | 19.11 - 20.15 |
| 52-Week Range | 18.87 - 39.66 |
| Beta | 0.55 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 27, 2026 |